The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Skyler Jay S since 2005.
This trader's CIK number is 1236386.
At the time of last reporting, Skyler Jay S was the Director of Dexcom Inc. (stock ticker symbol DXCM).
Also see all insider trading activities at Dexcom Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2012 | AMLN | 0 | $0 | 0 | $0 | 18,000 | $167,040 |
| 2011 | AMLN | 0 | $0 | 0 | $0 | 3,000 | $33,090 |
| 2010 | AMLN | 0 | $0 | 0 | $0 | 10,000 | $102,500 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2021 | DXCM | 0 | $0 | 20,000 | $8,527,680 | 0 | $0 |
| 2020 | DXCM | 0 | $0 | 25,806 | $5,616,340 | 0 | $0 |
| 2019 | DXCM | 0 | $0 | 0 | $0 | 25,806 | $118,191 |
| 2018 | DXCM | 0 | $0 | 61,464 | $5,318,026 | 61,464 | $377,470 |
| 2017 | DXCM | 0 | $0 | 31,890 | $2,491,565 | 31,890 | $233,115 |
| 2016 | DXCM | 0 | $0 | 60,000 | $5,551,025 | 0 | $0 |
| 2015 | DXCM | 0 | $0 | 105,000 | $7,680,575 | 45,000 | $719,128 |
| 2014 | DXCM | 0 | $0 | 150,000 | $6,131,654 | 0 | $0 |
| 2013 | DXCM | 70,000 | $1,085,000 | 0 | $0 | 0 | $0 |
| 2011 | DXCM | 8,000 | $56,760 | 0 | $0 | 0 | $0 |
| 2008 | DXCM | 20,000 | $99,400 | 0 | $0 | 0 | $0 |
| 2005 | DXCM | 39,950 | $461,490 | 0 | $0 | 0 | $0 |
1. Amylin Pharmaceuticals Inc (AMLN)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2012-05-11 | AMLN | Option Ex | 18,000 | 9.28 | 167,040 |
| 2011-05-24 | AMLN | Option Ex | 3,000 | 11.03 | 33,090 |
| 2010-05-28 | AMLN | Option Ex | 10,000 | 10.25 | 102,500 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2021-06-22 | DXCM | Sale | 20,000 | 426.38 | 8,527,680 |
| 2020-01-03 | DXCM | Sale | 25,806 | 217.64 | 5,616,340 |
| 2019-01-02 | DXCM | Option Ex | 25,806 | 4.58 | 118,191 |
| 2018-05-14 | DXCM | Option Ex | 30,000 | 4.58 | 137,400 |
| 2018-05-14 | DXCM | Sale | 30,000 | 88.00 | 2,640,000 |
| 2018-05-08 | DXCM | Option Ex | 31,464 | 7.63 | 240,070 |
| 2018-05-08 | DXCM | Sale | 31,464 | 85.11 | 2,678,026 |
| 2017-03-06 | DXCM | Option Ex | 31,890 | 7.31 | 233,115 |
| 2017-03-06 | DXCM | Sale | 31,890 | 78.13 | 2,491,565 |
| 2016-09-12 | DXCM | Sale | 10,000 | 93.00 | 930,000 |
| 2016-09-09 | DXCM | Sale | 25,000 | 94.07 | 2,351,800 |
| 2016-08-19 | DXCM | Sale | 25,000 | 90.77 | 2,269,225 |
| 2015-08-17 | DXCM | Sale | 20,000 | 96.65 | 1,932,980 |
| 2015-07-15 | DXCM | Sale | 20,000 | 81.69 | 1,633,880 |
| 2015-06-15 | DXCM | Sale | 20,000 | 70.67 | 1,413,420 |
| 2015-03-11 | DXCM | Sale | 21,564 | 60.00 | 1,293,904 |
| 2015-03-13 | DXCM | Option Ex | 16,500 | 21.09 | 348,067 |
| 2015-03-12 | DXCM | Sale | 6,936 | 60.00 | 416,160 |
| 2015-03-13 | DXCM | Sale | 16,500 | 60.01 | 990,231 |
| 2015-03-11 | DXCM | Option Ex | 21,564 | 12.00 | 258,768 |
| 2015-03-12 | DXCM | Option Ex | 6,936 | 16.19 | 112,293 |
| 2014-07-01 | DXCM | Sale | 17,800 | 40.02 | 712,284 |
| 2014-07-02 | DXCM | Sale | 12,200 | 40.09 | 489,110 |
| 2014-06-19 | DXCM | Sale | 30,000 | 40.00 | 1,200,000 |
| 2014-06-20 | DXCM | Sale | 30,000 | 40.00 | 1,200,000 |
| 2014-04-01 | DXCM | Sale | 30,000 | 41.29 | 1,238,790 |
| 2014-03-26 | DXCM | Sale | 30,000 | 43.05 | 1,291,470 |
| 2013-03-11 | DXCM | Buy | 70,000 | 15.50 | 1,085,000 |
| 2011-11-18 | DXCM | Buy | 8,000 | 7.09 | 56,760 |
| 2008-03-14 | DXCM | Buy | 20,000 | 4.97 | 99,400 |
| 2005-08-12 | DXCM | Buy | 9,950 | 10.20 | 101,490 |
| 2005-04-13 | DXCM | Buy | 30,000 | 12.00 | 360,000 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Skyler Jay S (Director of Dexcom Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.